Molecular Partners AG (MOLN)
4.50
-0.17
(-3.64%)
USD |
NASDAQ |
Sep 20, 16:00
4.50
0.00 (0.00%)
After-Hours: 18:55
Molecular Partners Accounts Receivable (Quarterly): 3.749M for June 30, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 3.749M |
March 31, 2024 | 3.523M |
December 31, 2023 | 0.3512M |
September 30, 2023 | 1.952M |
June 30, 2023 | 1.679M |
March 31, 2023 | 1.909M |
December 31, 2022 | 0.5619M |
September 30, 2022 | 1.774M |
June 30, 2022 | 2.703M |
March 31, 2022 | 3.763M |
December 31, 2021 | 25.94M |
September 30, 2021 | 5.974M |
June 30, 2021 | 8.591M |
December 31, 2020 | 0.182M |
June 30, 2020 | 2.696M |
December 31, 2019 | 0.0237M |
Date | Value |
---|---|
June 30, 2019 | 2.239M |
June 30, 2019 | 2.239M |
December 31, 2018 | 50.10M |
June 30, 2018 | 1.151M |
June 30, 2018 | 1.151M |
December 31, 2017 | 0.1725M |
June 30, 2017 | 1.152M |
June 30, 2017 | 1.152M |
December 31, 2016 | 0.0324M |
June 30, 2016 | 1.303M |
June 30, 2016 | 1.303M |
December 31, 2015 | 0.8589M |
June 30, 2015 | 16.28M |
June 30, 2015 | 16.28M |
December 31, 2014 | 2.884M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.0237M
Minimum
Dec 2019
25.94M
Maximum
Dec 2021
4.086M
Average
2.324M
Median
Accounts Receivable (Quarterly) Benchmarks
AC Immune SA | 0.00 |
CRISPR Therapeutics AG | 0.00 |
Addex Therapeutics Ltd | 0.1288M |
NLS Pharmaceutics Ltd | -- |
MoonLake Immunotherapeutics | -- |